Qube Research & Technologies (QRT)
SHPH icon

Qube Research & Technologies (QRT)’s Shuttle Pharmaceuticals SHPH Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SHPH Stock Details SHPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-12
Closed -$32.7K – 2950
2023
Q1 		$32.7K Sell
12
-8
-40% -$28.7K ﹤0.01% 2262
2022
Q4 		$76.6K Hold
20
– – ﹤0.01% 2060
2022
Q3 		$179K Buy
+20
New +$815K ﹤0.01% 1805

Other funds holding SHPH

AC
Ayrton Capital Westport, Connecticut $14.7M AUM 12.82% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Qube Research & Technologies (QRT)'s SHPH Position: Q2 2023 in Review

Qube Research & Technologies (QRT) sold out of Shuttle Pharmaceuticals (SHPH) in Q2 2023, closing a stake of 12 shares — an estimated $32.7K sold.

Qube Research & Technologies (QRT) first reported a position in SHPH in Q3 2022 and held it in 3 quarters. The position peaked at $179K in Q3 2022. 2 funds tracked by Wall St. Rank hold SHPH as of Q2 2023.

  • Qube Research & Technologies (QRT) reported no remaining Shuttle Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 12 Shuttle Pharmaceuticals shares in Q2 2023, an estimated $32.7K.
  • Qube Research & Technologies (QRT) first reported a position in Shuttle Pharmaceuticals in Q3 2022 and held it in 3 quarters.
  • Qube Research & Technologies (QRT)'s Shuttle Pharmaceuticals position peaked at $179K in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Shuttle Pharmaceuticals as of Q2 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2023, filed 14 Aug 2023.